Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N M Navone

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
The International Journal of Biochemistry|January 1, 1990
Heme regulation in mouse mammary carcinoma and liver of tumor bearing mice--I. Effect of allyl-isopropylacetamide and veronal on delta-aminolevulinate synthetase, cytochrome P-450 and cytochrome oxidaseN M Navone, C F Polo, R M Dinger, et al.
The International Journal of Biochemistry|January 1, 1990
Heme biosynthesis in human breast cancer--mimetic "in vitro" studies and some heme enzymic activity levelsN M Navone, C F Polo, A L Frisardi, et al.
The Journal of Urology|November 24, 1999
Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2aX Y Zhao, B Boyle, A V Krishnan, et al.
Ecotoxicology and Environmental Safety|December 1, 1995
Zinc aminolevulinic acid dehydratase reactivation index as a tool for diagnosis of lead exposureC F Polo, S G Afonso, N M Navone, et al.
General Pharmacology|January 1, 1991
The effect of griseofulvin on the heme pathway--II. An exhaustive analysis during short and long-term challengeN M Navone, A M Buzaleh, C F Polo, et al.
General Pharmacology|August 1, 1997
Griseofulvin-induced hepatopathy due to abnormalities in heme pathwayC F Polo, A M Buzaleh, E S Vazquez, et al.
Nature Medicine|June 3, 2000
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptorX Y Zhao, P J Malloy, A V Krishnan, et al.
General Pharmacology|January 1, 1990
In vivo prevention and reversal by the antimitotic colchicine and other related compounds of some porphyrinogenic drug action on heme pathwayS G Afonso, C F Polo, N M Navone, et al.
The Journal of Urology|February 26, 1999
p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potentialN M Navone, M E Labate, P Troncoso, et al.
Cancer Genetics and Cytogenetics|November 3, 1998
Structural alterations of chromosome 5 in twelve human prostate cancer cell linesM Ozen, N M Navone, A S Multani, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The International Journal of Biochemistry|January 1, 1990
Heme regulation in mouse mammary carcinoma and liver of tumor bearing mice--I. Effect of allyl-isopropylacetamide and veronal on delta-aminolevulinate synthetase, cytochrome P-450 and cytochrome oxidaseN M Navone, C F Polo, R M Dinger, et al.
The International Journal of Biochemistry|January 1, 1990
Heme biosynthesis in human breast cancer--mimetic "in vitro" studies and some heme enzymic activity levelsN M Navone, C F Polo, A L Frisardi, et al.
The Journal of Urology|November 24, 1999
Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2aX Y Zhao, B Boyle, A V Krishnan, et al.
Ecotoxicology and Environmental Safety|December 1, 1995
Zinc aminolevulinic acid dehydratase reactivation index as a tool for diagnosis of lead exposureC F Polo, S G Afonso, N M Navone, et al.
General Pharmacology|January 1, 1991
The effect of griseofulvin on the heme pathway--II. An exhaustive analysis during short and long-term challengeN M Navone, A M Buzaleh, C F Polo, et al.
General Pharmacology|August 1, 1997
Griseofulvin-induced hepatopathy due to abnormalities in heme pathwayC F Polo, A M Buzaleh, E S Vazquez, et al.
Nature Medicine|June 3, 2000
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptorX Y Zhao, P J Malloy, A V Krishnan, et al.
General Pharmacology|January 1, 1990
In vivo prevention and reversal by the antimitotic colchicine and other related compounds of some porphyrinogenic drug action on heme pathwayS G Afonso, C F Polo, N M Navone, et al.
The Journal of Urology|February 26, 1999
p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potentialN M Navone, M E Labate, P Troncoso, et al.
Cancer Genetics and Cytogenetics|November 3, 1998
Structural alterations of chromosome 5 in twelve human prostate cancer cell linesM Ozen, N M Navone, A S Multani, et al.
Pageof 3